MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Acrivastine

Acrivastine 8mg capsules

Use with caution

Stability notes for Acrivastine 8mg capsules

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Benadryl Allergy Releif (McNeil Products) and Acrivastine 8mg capsules (Brown & Burk UK Ltd).

Suppliers (6) of Acrivastine 8mg capsules
Acrivastine 8mg capsules (A A H Pharmaceuticals Ltd)
Acrivastine 8mg capsules (Alliance Healthcare (Distribution) Ltd)
Acrivastine 8mg capsules (Brown & Burk UK Ltd)
Acrivastine 8mg capsules (Medihealth (Northern) Ltd)
Allergy Relief 8mg capsules (Brown & Burk UK Ltd)
Benadryl Allergy Relief 8mg capsules (McNeil Products Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.